Exelixis Clinical Site #141
São Paulo 01327-001
0 studies enrolling now · 1 studies all time
What they study most
Renal Cell Carcinoma
Studies at this site
Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
— Running, not enrolling